Clinical Trials Browser

Phase 1/2 × Head and Neck Neoplasms × duvelisib × Clear all

NCT04193293 2023-09-21

A Study of Duvelisib in Combination With Pembrolizumab in Head and Neck Cancer

Phase 1/2 Terminated

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms